1/20
10:51 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
1/20
10:51 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
1/20
08:02 am
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
1/20
07:17 am
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/12
04:11 pm
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "outperform" rating reaffirmed by analysts at Wolfe Research.
Low
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "outperform" rating reaffirmed by analysts at Wolfe Research.
1/12
04:11 pm
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "outperform" rating reaffirmed by analysts at Wolfe Research.
Low
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "outperform" rating reaffirmed by analysts at Wolfe Research.
11/20
06:03 am
slno
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/20
06:03 am
slno
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/18
11:44 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
11/18
11:44 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
11/18
09:00 am
slno
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
11/18
09:00 am
slno
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
11/17
04:17 pm
slno
Soleno Therapeutics initiated with an Outperform at Wolfe Research
Low
Report
Soleno Therapeutics initiated with an Outperform at Wolfe Research
11/17
04:17 pm
slno
Soleno Therapeutics initiated with an Outperform at Wolfe Research
Low
Report
Soleno Therapeutics initiated with an Outperform at Wolfe Research